Infectious complications of percutaneous central venous catheterization in pediatric patients

被引:49
作者
Garcia-Teresa, M. Angeles
Casado-Flores, Juan
Dominguez, M. Angel Delgado
Roqueta-Mas, Jorge
Cambra-Lasaosa, Francisco
Concha-Torre, Andres
Fernandez-Perez, Cristina
机构
[1] Hop Nino Jesus, Pediat Intens Care Unit, Madrid 28009, Spain
[2] Univ Autonoma Madrid, Hop Infantil La Paz, Pediat Intens Care Unit, Madrid, Spain
[3] Hosp Gen Valle Hebron, Pediat Intens Care Unit, Barcelona, Spain
[4] Hosp Clin S Joan de Deu, Pediat Intens Care Unit, Barcelona, Spain
[5] Univ Oviedo, Hosp Cent Asturias, Pediat Intens Care Unit, E-33080 Oviedo, Spain
[6] Hosp Clin San Carlos, Epidemiol Unit, Dept Prevent Med, Madrid, Spain
关键词
catheter-related infection; children; multicenter study; multivariate;
D O I
10.1007/s00134-006-0508-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Analysis of infectious complications and risk factors in percutaneous central venous catheters. Design: One-year observational, prospective, multicenter study (1998-1999). Setting: Twenty Spanish pediatric intensive care units. Patients: Eight hundred thirty-two children aged 0-14 years. Intervention: None. Measurements and main results: One thousand ninety-two catheters were analyzed. Seventy-four (6.81%) catheter-related bloodstream infections (CRBSI) were found. The CRBSI rate was 6.4 per 1,000 CVC days (95% CI 5.0-8.0). Risk factors for CRBSI were weight under 8 kg (p < 0.001), cardiac failure (RR 2.69; 95% CI 1.95-4.38; p < 0.001), cancer (RR 1.66; 95% CI 0.97-2.78; p = 0.05), silicone catheters (RR 2.82; 95% CI 1.49-5.35; p = 0.006), guidewire exchange catheterization (p = 0.002), obstructed catheters (RR 2.67; 95% CI 1.63-4.39; p < 0.001), and more than 12 days' indwelling time (RR 5.9; 95% CI 3.63-9.41; p < 0.001). Multivariate Cox regression identified lower patient weight (HR 2.4; 95% CI 1.11-5.19; p = 0.002), guidewire exchange catheterization (HR 2.2; 95% CI 1.07-4.54; p = 0.049) and more than 12 days' indwelling time (HR 1.97; 95% CI 0.89-4.36; p = 0.089) as significant independent predictors of CRBSI. Factors which protected against infection were the use of povidone-iodine on hubs (HR 0.42; 95% CI 0.19-0.96; p = 0.025) and porous versus impermeable dressing (HR 0.41; 95% CI 0.23-0.74; p = 0.004). Two children (0.24%) died from endocarditis following catheter-related sepsis due to Stenotrophomonas maltophilia in one case and P. aeruginosa in the other. Conclusions: Catheter-related sepsis is associated with lower patient weight and more than 12 days' indwelling time, but not with the insertion site. Cleaning hubs with povidone-iodine protects from infection.
引用
收藏
页码:466 / 476
页数:11
相关论文
共 49 条
[1]   Skin antiseptic in reducing the risk of central venous catheter-related infections [J].
Assadian, O .
CRITICAL CARE MEDICINE, 2004, 32 (03) :887-888
[2]  
Casado Flores J, 2001, PEDIATR CRIT CARE ME, V2, P57
[3]   SUBCLAVIAN VEIN CATHETERIZATION IN CRITICALLY ILL CHILDREN - ANALYSIS OF 322 CANNULATIONS [J].
CASADOFLORES, J ;
VALDIVIELSOSERNA, A ;
PEREZJURADO, L ;
POZOROMAN, J ;
MONLEONLUQUE, M ;
GARCIAPEREZ, J ;
RUIZBELTRAN, A ;
GARCIATERESA, MA .
INTENSIVE CARE MEDICINE, 1991, 17 (06) :350-354
[4]   Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: A meta-analysis [J].
Chaiyakunapruk, N ;
Veenstra, DL ;
Lipsky, BA ;
Saint, S .
ANNALS OF INTERNAL MEDICINE, 2002, 136 (11) :792-801
[5]  
COOB DK, 1992, NEW ENGL J MED, V327, P1062
[6]   Central venous catheter replacement strategies: A systematic review of the literature [J].
Cook, D ;
Randolph, A ;
Kernerman, P ;
Cupido, C ;
King, D ;
Soukup, C ;
BrunBuisson, C .
CRITICAL CARE MEDICINE, 1997, 25 (08) :1417-1424
[7]  
Daghistani D, 1996, MED PEDIATR ONCOL, V26, P405, DOI 10.1002/(SICI)1096-911X(199606)26:6<405::AID-MPO6>3.3.CO
[8]  
2-K
[9]   POSITIVE TIP CULTURES AND RELATED RISK-FACTORS ASSOCIATED WITH INTRAVASCULAR CATHETERIZATION IN PEDIATRIC CARDIAC PATIENTS [J].
DAMEN, J ;
VANDERTWEEL, I .
CRITICAL CARE MEDICINE, 1988, 16 (03) :221-228
[10]  
de Jonge Rogier C J, 2005, Pediatr Crit Care Med, V6, P329, DOI 10.1097/01.PCC.0000161074.94315.0A